Prescott Group Capital Management L.L.C. Grows Holdings in The Beauty Health Company $SKIN

Prescott Group Capital Management L.L.C. raised its position in shares of The Beauty Health Company (NASDAQ:SKIN) by 29.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 835,939 shares of the company’s stock after purchasing an additional 189,141 shares during the quarter. Prescott Group Capital Management L.L.C. owned 0.66% of Beauty Health worth $1,597,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of SKIN. Goldman Sachs Group Inc. raised its position in shares of Beauty Health by 5.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock valued at $892,000 after purchasing an additional 31,880 shares during the period. Grimes & Company Inc. increased its stake in Beauty Health by 85.2% in the 2nd quarter. Grimes & Company Inc. now owns 406,987 shares of the company’s stock worth $777,000 after buying an additional 187,226 shares in the last quarter. Newman Dignan & Sheerar Inc. raised its holdings in Beauty Health by 28.1% during the second quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock valued at $174,000 after acquiring an additional 20,000 shares during the period. SCS Capital Management LLC purchased a new position in shares of Beauty Health in the first quarter valued at about $67,000. Finally, Nuveen LLC purchased a new position in shares of Beauty Health in the first quarter valued at about $59,000. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Stock Up 8.5%

Shares of SKIN opened at $1.40 on Friday. The company has a debt-to-equity ratio of 4.91, a current ratio of 5.15 and a quick ratio of 4.15. The stock has a market capitalization of $177.55 million, a price-to-earnings ratio of -6.36 and a beta of 1.19. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $2.69. The business’s 50 day simple moving average is $1.80 and its 200-day simple moving average is $1.75.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, November 6th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Beauty Health had a negative net margin of 3.87% and a negative return on equity of 20.42%. The business had revenue of $70.66 million during the quarter, compared to analysts’ expectations of $68.33 million. Beauty Health has set its FY 2025 guidance at EPS. As a group, equities analysts expect that The Beauty Health Company will post -0.25 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SKIN. Cowen reiterated a “hold” rating on shares of Beauty Health in a research report on Monday, September 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Beauty Health in a research note on Friday, October 31st. Wall Street Zen cut shares of Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday. Stifel Nicolaus boosted their target price on shares of Beauty Health from $3.00 to $4.00 and gave the stock a “hold” rating in a report on Friday, August 1st. Finally, TD Cowen raised their target price on shares of Beauty Health from $2.00 to $2.50 and gave the company a “hold” rating in a research note on Monday, September 22nd. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.81.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.